Sharad A Ghamande

Department Chair

  • 776 Citations
  • 14 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 776 Citations
  • 14 h-Index
  • 33 Article
  • 2 Letter

A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer

Mysona, D., Pyrzak, A., Purohit, S. B., Zhi, W., Sharma, A. K., Tran, L., Tran, P., Bai, S., Rungruang, B. J., Ghamande, S. A. & She, J-X., Mar 1 2019, In : Gynecologic Oncology. 152, 3, p. 574-580 7 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Blood Proteins
Recurrence
Disease-Free Survival
Proteins
4 Citations (Scopus)

Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

Falchook, G., Coleman, R. L., Roszak, A., Behbakht, K., Matulonis, U., Ray-Coquard, I., Sawrycki, P., Duska, L. R., Tew, W., Ghamande, S. A., Lesoin, A., Schwartz, P. E., Buscema, J., Fabbro, M., Lortholary, A., Goff, B., Kurzrock, R., Martin, L. P., Gray, H. J., Fu, S. & 6 others, Sheldon-Waniga, E., Lin, H. M., Venkatakrishnan, K., Zhou, X., Leonard, E. J. & Schilder, R. J., Jan 1 2019, In : JAMA Oncology. 5, 1

Research output: Contribution to journalArticle

Paclitaxel
Ovarian Neoplasms
Randomized Controlled Trials
Breast Neoplasms
Disease-Free Survival

Bovine Pericardial Graft for Second-Trimester Cesarean Scar Dehiscence

Stephens, A., Patel, K., Davis, J. & Ghamande, S. A., Feb 1 2019, In : Obstetrics and Gynecology. 133, 2, p. 364-367 4 p.

Research output: Contribution to journalArticle

Second Pregnancy Trimester
Cicatrix
Transplants
Pregnancy
Premature Obstetric Labor
1 Citation (Scopus)

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 1 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Ovarian Neoplasms
Placebos
Disease-Free Survival
12 Citations (Scopus)

A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

Matei, D., Ghamande, S. A., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In : Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

Research output: Contribution to journalArticle

Carboplatin
Platinum
Ovarian Neoplasms
Pharmacokinetics
Clinical Trials